Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SPOT-03
- Development stage
- Unknown
- Lead developer
- Shanghai SiPenoin Biotechnology
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Gene Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
SPOT-03 is an investigational non-viral gene therapy developed by Spot BioSystems for the treatment of Duchenne muscular dystrophy (DMD). It utilizes a proprietary extracellular vesicle (EV)-mediated delivery platform to transport mRNA encoding a functional version of the dystrophin protein directly to muscle cells. Unlike traditional viral vector-based gene therapies, SPOT-03's EV-mediated approach is designed to be non-immunogenic, potentially allowing for repeat administration and avoiding the cargo size limitations associated with adeno-associated virus (AAV) vectors. The program is currently being evaluated in a Phase 1 first-in-human clinical trial.
02
Targets
DMD (Dystrophin)
Beyond the preview
Go deeper on SPOT-03.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SPOT-03.